GENERATIVE AI - PETS
Fidotek Corp is the Generative AI bioscience company focused on 120 million US pets. Its Next-Gen AI platform is poised to be the single-most consequential ecosystem digitally transforming multiple high margin verticals in the burgeoning $135B pet industry via bespoke revenue models.
- Personalized Web3 Retail
- Pet Diagnostics
- Pet Health Insurance
- Advanced Telemedicine
- Drug Development
And as an industry patent leader, no single company currently offers a comparable solution. None.
Andy Gibbs, Founder & CEO • email: Fido@Fidotek.com
QUALIFIED ARIZONA BIOSCIENCE BUSINESS
Under Arizona’s Angel Investment program A.R.S. § 41-1518, accredited Angel Investors may receive 35% tax credit on the capital invested under traditional startup investment vehicles, and also receive capital gains exemption on profits made from those investments.
PATENT NOTICE
Protected by one or more of these US Patents and Applications: USD761,494; US9,928,511; US10,115,110; US10,506,798; US10,674,702; US11,206,816; US11,758,879; US2018/0228128; US2020/0381119; US2018/0168126; US2016/0192619; US2017/0330194; US2018/0218373; US2020/0120901; US2020/0404886; US2018/0235183; US2020/0404886; US2020/0305387